LMF
SRNE

LMR Master Fund’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

LMR Master Fund’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$915K Buy
+113,000
New +$994K 0.09% 236

Other funds holding SRNE

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

LMR Master Fund's SRNE Position: Q4 2013 in Review

LMR Master Fund opened a new position in Sorrento Therapeutics, Inc. (SRNE) in Q4 2013: 113,000 shares worth $915K. The stake represents 0.09% of the portfolio and ranks #236 among its holdings.

15 funds tracked by Wall St. Rank hold SRNE as of Q4 2013.

  • LMR Master Fund held 113,000 shares of Sorrento Therapeutics, Inc. worth $915K as of Q4 2013.
  • Sorrento Therapeutics, Inc. was a new LMR Master Fund position in Q4 2013.
  • Sorrento Therapeutics, Inc. made up 0.09% of LMR Master Fund's portfolio in Q4 2013, its #236 holding.
  • 15 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.